Inogen [INGN] vs Stryker [SYK] Detailed Stock Comparison

Inogen Inc.

NASDAQ
Loading...

Stryker Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Inogen Inc. wins in 6 metrics, Stryker Corporation wins in 13 metrics, with 0 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Inogen Inc. Stryker Corporation Better
P/E Ratio (TTM) -8.14 39.21 Stryker Corporation
Price-to-Book Ratio 0.99 5.62 Inogen Inc.
Debt-to-Equity Ratio 9.09 72.97 Inogen Inc.
PEG Ratio 0.22 0.72 Inogen Inc.
EV/EBITDA -9.16 19.90 Stryker Corporation
Profit Margin (TTM) -6.52% 12.92% Stryker Corporation
Operating Margin (TTM) -12.21% 27.24% Stryker Corporation
EBITDA Margin (TTM) N/A 27.24% N/A
Return on Equity -12.43% 15.08% Stryker Corporation
Return on Assets (TTM) -6.35% 7.92% Stryker Corporation
Free Cash Flow (TTM) $-21.60M $4.28B Stryker Corporation
Dividend Yield N/A 0.97% N/A
1-Year Return 0.93% -20.27% Inogen Inc.
Price-to-Sales Ratio (TTM) 0.54 5.02 Inogen Inc.
Enterprise Value $87.44M $138.30B Stryker Corporation
EV/Revenue Ratio 0.25 5.51 Inogen Inc.
Gross Profit Margin (TTM) 43.12% 64.54% Stryker Corporation
Revenue per Share (TTM) $13 $66 Stryker Corporation
Earnings per Share (Diluted) $-0.86 $8.40 Stryker Corporation
Beta (Stock Volatility) 1.71 0.93 Stryker Corporation
Short % of Float 4.16% 1.20% Stryker Corporation

Inogen Inc. vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

INGN
SYK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Inogen Inc.-1.97%-7.45%-12.63%-1.46%-9.64%-8.14%
Stryker Corporation0.58%-6.29%0.83%-24.22%-20.01%-15.76%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Inogen Inc.0.93%-40.02%-89.81%-86.81%-57.16%-57.16%
Stryker Corporation-20.27%9.63%21.15%168.66%406.79%583.29%

Performance & Financial Health Analysis: Inogen Inc. vs Stryker Corporation

MetricINGNSYK
Market Information
Market Cap i$190.35M$126.25B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i313,1051,881,406
90 Day Avg. Volume i253,0822,161,139
Last Close$5.97$295.00
52 Week Range$5.34 - $9.13$281.00 - $404.87
% from 52W High-34.61%-27.14%
All-Time High$287.79 (Sep 10, 2018)$406.19 (Jan 27, 2025)
% from All-Time High-97.93%-27.37%
Growth Metrics
Quarterly Revenue Growth0.02%0.11%
Quarterly Earnings Growth0.02%0.56%
Financial Health
Profit Margin (TTM) i-0.07%0.13%
Operating Margin (TTM) i-0.12%0.27%
Return on Equity (TTM) i-0.12%0.15%
Debt to Equity (MRQ) i9.0972.97
Cash & Liquidity
Book Value per Share (MRQ)$7.06$58.61
Cash per Share (MRQ)$4.39$10.71
Operating Cash Flow (TTM) i$-11,216,000$5.04B
Levered Free Cash Flow (TTM) i$-21,157,376$4.17B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A$3.40

Valuation & Enterprise Metrics Analysis: Inogen Inc. vs Stryker Corporation

MetricINGN (Apr 24, 2026)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-8.1439.21
Forward P/E i-22.4519.67
PEG Ratio i0.220.72
Price to Sales (TTM) i0.545.02
Price to Book (MRQ) i0.995.62
Market Capitalization
Market Capitalization i$190.35M$126.25B
Enterprise Value i$87.44M$138.30B
Enterprise Value Metrics
Enterprise to Revenue i0.255.51
Enterprise to EBITDA i-9.1619.90
Risk & Other Metrics
Beta i1.710.93
Book Value per Share (MRQ) i$7.06$58.61

Financial Statements Comparison: Inogen Inc. vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricINGN (2025)SYK (2025)
Revenue/Sales i348.67M25.12B
Cost of Goods Sold i194.40M9.05B
COGS % of Revenue i55.8%36.0%
Gross Profit i154.27M16.07B
Gross Margin i44.2%64.0%
Research & Development i19.40M1.62B
Operating Income (EBIT) i-30.21M5.06B
Operating Margin i-8.7%20.1%
EBITDA i-9.55M6.48B
EBITDA Margin i-2.7%25.8%
Pre-Tax Income i-23.38M4.51B
Pre-Tax Income % of Revenue i-6.7%18.0%
Income Tax i-632,0001.27B
Income Tax % of Revenue i-0.2%5.0%
Net Income (Profit) i-22.75M3.25B
Profit Margin i-6.5%12.9%

Balance Sheet & Liquidity Metrics

MetricINGN (2025)SYK (2025)
Cash & Equivalents i103.73M4.01B
Total Current Assets i198.30M14.76B
Total Current Assets % of Revenue i56.9%58.7%
Total Current Liabilities i63.54M7.79B
Total Current Liabilities % of Revenue i18.2%31.0%
Long-Term Debt i14.31M14.86B
Long-Term Debt % of Revenue i4.1%59.2%
Total Shareholders Equity i192.23M22.42B
Retained Earnings i-175.58M20.47B
Retained Earnings % of Revenue i-50.4%81.5%
Property, Plant & Equipment i101.83M1.79B

Cash Flow Statement Comparison

MetricINGN (2025)SYK (2025)
Operating Cash Flow i-16.25M4.70B
Operating Cash Flow % of Revenue i-4.7%18.7%
Capital Expenditures i-10.38M-761.00M
Free Cash Flow i-21.60M4.28B
FCF Margin i-6.2%17.1%
Debt Repayment iN/A-1.40B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricINGNSYK
Shares Short i1.12M4.42M
Short Ratio i4.291.95
Short % of Float i4.16%1.20%
Shares Outstanding i27.23M382.50M
Float Shares i24.03M346.55M
% Held by Insiders i11.97%5.37%
% Held by Institutions i76.68%82.09%
% Held by Public i11.35%12.54%

Dividend Analysis & Yield Comparison: Inogen Inc. vs Stryker Corporation

MetricINGNSYK
Last 12-Month Dividend iN/A$3.40
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A$3.23
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$9.69
Ex-Dividend DateN/ADec 31, 2025